Overall rank by patents
#5,328
Across all tracked assignees
USPTO PatentsView assignee record — 65 granted patents across 12 technology areas, active 2019–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).
THERAGUN, INC. has been granted 65 US utility patents between 2019 and 2022, placing THERAGUN, INC. at rank #5,328 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.0 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, THERAGUN, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 29.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 50 grants, compared with 15 in the 2015–2019 window — a +233% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. THERAGUN, INC.'s 5.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark THERAGUN, INC. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
THERAGUN, INC.
65 patents
What this shows THERAGUN holds 65 patents — placing it at rank #5,328 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 15 | 23.1% |
| 2020 | 25 | 38.5% |
| 2021 | 23 | 35.4% |
| 2022 | 2 | 3.1% |
Top 12 of 12 technology areas
Overall rank by patents
#5,328
Across all tracked assignees
29.9 out of 100
THERAGUN, INC.'s primary CPC class — all holders and yearly trends
See where THERAGUN, INC. ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.